New Pharma/Device Deals

Restricted access

The US Food and Drug Administration (FDA) has approved a new stent for use in the treatment of kidney failure patients who are on hemodialysis.

Bard, now a part of healthcare tech giant Becton Dickinson (Franklin Lakes, NJ) was the originator of the Covera vascular covered stent. The stent, which is used to re-open narrowed access circuits in an arteriovenous fistula, has a “helical design for radial strength and flexibility” and an “atraumatic” tip for insertion comfort, according to According to Becton Dickinson, it is the first and only covered stent to be approved in the US